Are you one of those who continuously complain about lower back pain?
Then we might have some important news for you.
According to a recent study, there is available evidence that strongly supports the involvement of estrogen deficiency in disc degeneration, as well as the benefits of hormone therapy (HT) on the total lumbar disc height in postmenopausal women.
However, the study detailed in the article "Association between menopause and lumbar disc degeneration: an MRI study of 1,566 women and 1,382 men" is the first known to include a portion of age-matched men as a comparison group.
The study shows that how men and women fare with regard to disc degeneration, as measured by magnetic resonance imaging, as they age.
Whereas young, age-matched men were more susceptible to disc degeneration than premenopausal women were, postmenopausal women had a significant tendency to develop more severe disc degeneration than age-matched men compared with premenopausal and perimenopausal women.
The most dramatic difference was seen in the first 15 years after menopause onset, although the authors note that further studies are needed to determine whether age or menopause plays a more important role in the progression of disc degeneration in the lumbar spine.
Dr. JoAnn Pinkerton, executive director of The North American Menopause Society (NAMS), said, "This study shows that menopause is associated with more severe disc degeneration.
Prevention of disc degeneration of the lumbar spine may be another potential benefit for symptomatic menopausal women who may be candidates for hormone therapy."
The study was published in journal Menopause.
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)